Related Experiment Video

Updated: Aug 22, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

Ryanodine receptor channelopathies

Nancy A Benkusky1, Emily F Farrell, Héctor H Valdivia

  • 1Department of Physiology, University of Wisconsin Medical School, Madison, WI 53706, USA.

Biochemical and Biophysical Research Communications
|September 1, 2004
PubMed

Insights

Ryanodine receptors (RyR) are crucial for muscle contraction. Their dysfunction, causing abnormal calcium release, underlies serious muscle diseases like malignant hyperthermia and cardiac arrhythmias.

Area of Science:

  • Physiology
  • Molecular Biology
  • Genetics

Background:

  • Ryanodine receptors (RyR) are sarcoplasmic reticulum Ca2+ release channels essential for muscle contraction.
  • RyRs are tightly regulated by cellular factors to prevent dysfunction.
  • RyR dysfunction is linked to various genetic and acquired muscle syndromes.

Purpose of the Study:

  • To review the role of RyR dysfunction in muscle diseases.
  • To highlight the mechanisms underlying RyR-related genetic disorders.
  • To discuss the implications of RyR alterations in cardiac and skeletal myopathies.

Main Methods:

  • Literature review of studies on Ryanodine receptors.
  • Analysis of genetic mutations associated with RyR dysfunction.
  • Examination of molecular mechanisms of RyR regulation and malfunction.

Main Results:

  • RyR dysfunction, characterized by enhanced Ca2+ release, is a common mechanism in muscle disorders.
  • Skeletal muscle diseases like malignant hyperthermia and central core disease stem from RYR1 mutations.
  • Cardiac conditions including catecholaminergic polymorphic ventricular tachycardia and heart failure are linked to RYR2 mutations or altered phosphorylation.

Conclusions:

  • RyR dysfunction is a fundamental cause of various skeletal and cardiac muscle diseases.
  • Specific RYR1 and RYR2 mutations lead to distinct clinical syndromes.
  • Further research into RyR regulation and phosphorylation is critical for understanding and treating muscle disorders.

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella11:31

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella

Published on: November 30, 2018

Related Concept Videos

Channel Rhodopsins01:11

Channel Rhodopsins

Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: